Calando Pharmaceuticals initiates Phase II ovarian cancer study
This Phase II study is designed to determine if IT-101 treatment initiated after a standard second line course of platinum chemotherapy in patients who have stable disease, a
SK bioscience is set to lead the Gates Foundation-fundedResearch Optimization & Trial Outcome Recommender (ROTOR) project, an AI-based platform aimed at reducing uncertainty in vaccine-development decisions.